Quince Therapeutics, Inc.QNCXNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -79 | -90↓14.5% | -52↑42.4% | -35↑33.4% | -57↓65.5% |
| Net Income | -77 | -90↓17.0% | -52↑42.6% | -31↑39.2% | -57↓81.1% |
| EBITDA | -79 | -90↓14.5% | -51↑43.3% | -27↑47.4% | -36↓34.2% |
| EPS Diluted | -2.63 | -3.03↓15.2% | -1.54↑49.2% | -0.84↑45.5% | -1.31↓56.0% |